Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort

Jorge Calderón‐Parra(Hospital Universitario Puerta de Hierro Majadahonda), Elena Múñez(Hospital Universitario Puerta de Hierro Majadahonda), Rocío Montejano-Sánchez(Hospital Universitario La Paz), José Aguareles(Hospital Universitario Quirónsalud Madrid), José Ramón Arribas(Hospital Universitario La Paz), Pablo Guisado‐Vasco(Hospital Universitario Quirónsalud Madrid), Ana Fernández‐Cruz, Marina Calvo‐Salvador(Hospital Universitario Puerta de Hierro Majadahonda), Guillermo Cuevas(Hospital Universitario Infanta Leonor), Vicente Estrada(Instituto de Salud Carlos III), António Ramos, Marta Erro-Iribarren(Hospital Universitario Puerta de Hierro Majadahonda)
Journal of Clinical Medicine
January 21, 2023
10.3390/jcm12030864
Cited by 11

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
|New England Journal of Medicine|2006|886
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
|The Lancet|2006|343